Serial intravascular ultrasound assessment of changes in coronary atherosclerotic plaque dimensions and composition: an update.

This manuscript reviews the use of serial intravascular ultrasound (IVUS) examination of coronary atherosclerosis in recent observational studies and randomized trials that revealed the effects of cholesterol-lowering and lipid-modifying therapies and offered novel insight into plaque progression and regression. We discuss the value of plaque progression-regression as complementary imaging endpoint and potential surrogate marker of cardiovascular event risk. In addition, the progress in serial assessment of coronary plaque composition and plaque vulnerability by radiofrequency-based analyses is reviewed. Finally, we report on the evaluation of true vessel remodelling in recent serial IVUS trials and discuss the future perspective of serial invasive imaging of coronary atherosclerosis.

[1]  S. Marso,et al.  Intravascular ultrasound radiofrequency analysis of coronary atherosclerosis: an emerging technology for the assessment of vulnerable plaque. , 2007, European heart journal.

[2]  J. Deckers,et al.  Long-term effect of perindopril on coronary atherosclerosis progression (from the perindopril's prospective effect on coronary atherosclerosis by angiography and intravascular ultrasound evaluation [PERSPECTIVE] study). , 2007, The American journal of cardiology.

[3]  P. Libby,et al.  Effect of Antihypertensive Agents on Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure The CAMELOT Study: A Randomized Controlled Trial , 2004 .

[4]  Dick M. Goedhart,et al.  Reproducibility of intravascular ultrasound radiofrequency data analysis: implications for the design of longitudinal studies , 2006, The International Journal of Cardiovascular Imaging.

[5]  R H Selzer,et al.  Progression of coronary artery disease predicts clinical coronary events. Long-term follow-up from the Cholesterol Lowering Atherosclerosis Study. , 1996, Circulation.

[6]  D. Cutler,et al.  Effect of Torcetrapib on the Progression of Coronary Atherosclerosis , 2007 .

[7]  E. Tuzcu,et al.  Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial. , 2008, JAMA.

[8]  W. Howard,et al.  Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary Atherosclerosis , 2008 .

[9]  D. Pennell,et al.  Surrogate markers for atherosclerotic disease , 2005, Current opinion in lipidology.

[10]  Deepak L. Bhatt,et al.  Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial. , 2008, JAMA.

[11]  T. Lüscher,et al.  A randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study , 2009, European heart journal.

[12]  C J Slager,et al.  Volumetric intracoronary ultrasound: a new maximum confidence approach for the quantitative assessment of progression-regression of atherosclerosis? , 1995, Atherosclerosis.

[13]  A. Lindsay,et al.  Form to function: current and future roles for atherosclerosis imaging in drug development , 2008, Nature Reviews Drug Discovery.

[14]  Raimund Erbel,et al.  Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. , 2006, JAMA.

[15]  R. Virmani,et al.  Pathology of the Vulnerable Plaque , 2006 .

[16]  Seung‐Jung Park,et al.  Comparison of virtual histology to intravascular ultrasound of culprit coronary lesions in acute coronary syndrome and target coronary lesions in stable angina pectoris. , 2007, American Journal of Cardiology.

[17]  E. Tuzcu,et al.  Coronary Plaque Classification With Intravascular Ultrasound Radiofrequency Data Analysis , 2002, Circulation.

[18]  Peter Libby,et al.  The forgotten majority: unfinished business in cardiovascular risk reduction. , 2005, Journal of the American College of Cardiology.

[19]  P. Shah,et al.  Mechanisms of plaque vulnerability and rupture. , 2003, Journal of the American College of Cardiology.

[20]  H. Fujita,et al.  Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound. , 2005, Journal of the American College of Cardiology.

[21]  R. Burrow,et al.  Heart , 2013, Feline Soft Tissue and General Surgery.

[22]  Frits Mastik,et al.  Effects of the Direct Lipoprotein-Associated Phospholipase A2 Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque , 2008, Circulation.

[23]  S. Lévesque,et al.  Effect of atherosclerotic regression on total luminal size of coronary arteries as determined by intravascular ultrasound. , 2006, The American journal of cardiology.

[24]  K. Shimada,et al.  Early Statin Treatment in Patients With Acute Coronary Syndrome: Demonstration of the Beneficial Effect on Atherosclerotic Lesions by Serial Volumetric Intravascular Ultrasound Analysis During Half a Year After Coronary Event: The ESTABLISH Study , 2004, Circulation.

[25]  Carl J Pepine,et al.  Effect of ACAT inhibition on the progression of coronary atherosclerosis. , 2006, The New England journal of medicine.

[26]  W. Bocksch,et al.  Effects of lipid-lowering therapy on coronary artery remodeling , 2004, Coronary artery disease.

[27]  C. Zarins,et al.  Compensatory enlargement of human atherosclerotic coronary arteries. , 1987, The New England journal of medicine.

[28]  Volker Klauss,et al.  Virtual histology , 2007, Heart.

[29]  G. Stone,et al.  Necrotic core and its ratio to dense calcium are predictors of high-risk non-ST-elevation acute coronary syndrome. , 2008, The American journal of cardiology.

[30]  Antonio Colombo,et al.  Clinical application and image interpretation in intracoronary ultrasound , 1998 .

[31]  Frits Mastik,et al.  Incidence of High-Strain Patterns in Human Coronary Arteries: Assessment With Three-Dimensional Intravascular Palpography and Correlation With Clinical Presentation , 2004, Circulation.

[32]  Akiko Maehara,et al.  A prospective natural-history study of coronary atherosclerosis. , 2011, The New England journal of medicine.

[33]  Gerald S. Berenson,et al.  Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis: the Bogalusa heart study , 1986 .

[34]  G. Pasterkamp.  Imaging of de novo atherosclerotic arterial remodeling: clinical sense or research sensibility? , 2009, Journal of the American College of Cardiology.

[35]  M. Brown,et al.  Heart Attacks: Gone with the Century? , 1996, Science.

[36]  J. Loscalzo.  Clinical trials in cardiovascular medicine in an era of marginal benefit, bias, and hyperbole. , 2005, Circulation.

[37]  Bruce R. Brodie,et al.  Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis A Randomized Controlled Trial , 2004 .

[38]  C. Tracy,et al.  American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. , 2001, Journal of the American College of Cardiology.

[39]  S. Achenbach,et al.  Influence of Lipid-Lowering Therapy on the Progression of Coronary Artery Calcification: A Prospective Evaluation , 2002, Circulation.

[40]  T. Haghfelt,et al.  Low variation and high reproducibility in plaque volume with intravascular ultrasound. , 2004, International journal of cardiology.

[41]  R. Erbel,et al.  Relation between baseline plaque burden and subsequent remodelling of atherosclerotic left main coronary arteries: a serial intravascular ultrasound study with long-term (> or =12 months) follow-up. , 2006, European heart journal.

[42]  A. Schmermund,et al.  Relationship Between Cardiovascular Risk as Predicted by Established Risk Scores Versus Plaque Progression as Measured by Serial Intravascular Ultrasound in Left Main Coronary Arteries , 2004, Circulation.

[43]  K. Miyauchi.  [Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH study]. , 2011, Nihon rinsho. Japanese journal of clinical medicine.

[44]  P. Fitzgerald,et al.  Plasma low-density lipoprotein reduction and structural effects on coronary atherosclerotic plaques by atorvastatin as clinically assessed with intravascular ultrasound radio-frequency signal analysis: a randomized prospective study. , 2005, American heart journal.

[45]  Paul Schoenhagen,et al.  Determinants of Arterial Wall Remodeling During Lipid-Lowering Therapy: Serial Intravascular Ultrasound Observations From the Reversal of Atherosclerosis With Aggressive Lipid Lowering Therapy (REVERSAL) Trial , 2006, Circulation.

[46]  Knud Erik Pedersen,et al.  Regression of Coronary Atherosclerosis by Simvastatin: A Serial Intravascular Ultrasound Study , 2004, Circulation.

[47]  J. LeLorier,et al.  Intensive versus moderate lipid lowering with statins after acute coronary syndromes. , 2004, The New England journal of medicine.

[48]  N. Bruining,et al.  Effect of perindopril on coronary remodelling: insights from a multicentre, randomized study. , 2007, European heart journal.

[49]  Johannes A. Schaar,et al.  Optical coherence tomography. , 2003, Cardiovascular radiation medicine.

[50]  Raimund Erbel,et al.  Intravascular ultrasound for the evaluation of therapies targeting coronary atherosclerosis. , 2007, Journal of the American College of Cardiology.

[51]  D. Herrington,et al.  Coronary angiography: more than meets the eye. , 1993, Circulation.

[52]  B Hillen,et al.  Relation of arterial geometry to luminal narrowing and histologic markers for plaque vulnerability: the remodeling paradox. , 1998, Journal of the American College of Cardiology.

[53]  G. Stone,et al.  In vivo virtual histology intravascular ultrasound correlates of risk factors for sudden coronary death in men: results from the prospective, multi-centre virtual histology intravascular ultrasound registry. , 2008, European heart journal.

[54]  R. Erbel,et al.  Relation between plaque progression and low-density lipoprotein cholesterol during aging as assessed with serial long-term (> or =12 months) follow-up intravascular ultrasound of the left main coronary artery. , 2006, The American journal of cardiology.

[55]  澤田 隆弘,et al.  Feasibility of combined use of intravascular ultrasound radiofrequency data analysis and optical coherence tomography for detecting thin-cap fibroatheroma , 2008 .

[56]  Hiroaki Shimokawa,et al.  Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm. , 2003, Journal of the American College of Cardiology.

[57]  Markus F Neurath,et al.  Virtual histology. , 2008, Best practice & research. Clinical gastroenterology.

[58]  Raimund Erbel,et al.  Relation Between Progression and Regression of Atherosclerotic Left Main Coronary Artery Disease and Serum Cholesterol Levels as Assessed With Serial Long-Term (≥12 Months) Follow-Up Intravascular Ultrasound , 2003, Circulation.

[59]  Intensive lipid lowering with atorvastatin in patients with stable coronary disease. , 2005, The New England journal of medicine.

[60]  V. Fuster,et al.  Angiographic progression of coronary artery disease and the development of myocardial infarction. , 1988, Journal of the American College of Cardiology.

[61]  S. Meyers,et al.  Angiographically silent left main disease detected by intravascular ultrasound: a marker for future adverse cardiac events. , 2003, American heart journal.

[62]  Marco Valgimigli,et al.  In vivo intravascular ultrasound-derived thin-cap fibroatheroma detection using ultrasound radiofrequency data analysis. , 2005, Journal of the American College of Cardiology.

[63]  E. Tuzcu,et al.  -Blockers and Progression of Coronary Atherosclerosis: Pooled Analysis of 4 Intravascular Ultrasonography Trials , 2007, Annals of Internal Medicine.

[64]  Fernando Alfonso,et al.  Effects of the Acyl Coenzyme A:Cholesterol Acyltransferase Inhibitor Avasimibe on Human Atherosclerotic Lesions , 2004, Circulation.

[65]  J. Kastelein,et al.  Ultrasound imaging techniques for the evaluation of cardiovascular therapies. , 2008, European heart journal.

[66]  S E Nissen,et al.  Extent and direction of arterial remodeling in stable versus unstable coronary syndromes : an intravascular ultrasound study. , 2000, Circulation.

[67]  R. Virmani,et al.  Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. , 1997, The New England journal of medicine.

[68]  D G Vince,et al.  Arterial remodeling and coronary artery disease: the concept of "dilated" versus "obstructive" coronary atherosclerosis. , 2001, Journal of the American College of Cardiology.

[69]  Colin Berry,et al.  Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial. , 2007, JAMA.

[70]  T. Craven,et al.  Prognostic Significance of Progression of Coronary Atherosclerosis , 1993, Circulation.

[71]  P. Allhoff,et al.  Bogalusa Heart Study , 2020, Encyclopedia of Behavioral Medicine.

[72]  M Schartl,et al.  Use of Intravascular Ultrasound to Compare Effects of Different Strategies of Lipid-Lowering Therapy on Plaque Volume and Composition in Patients With Coronary Artery Disease , 2001, Circulation.

[73]  Paul Schoenhagen,et al.  Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. , 2003, JAMA.

[74]  C von Birgelen,et al.  Plaque distribution and vascular remodeling of ruptured and nonruptured coronary plaques in the same vessel: an intravascular ultrasound study in vivo. , 2001, Journal of the American College of Cardiology.

[75]  R. Virmani,et al.  Accuracy of in vivo coronary plaque morphology assessment: a validation study of in vivo virtual histology compared with in vitro histopathology. , 2006, Journal of the American College of Cardiology.

[76]  M. Stoel,et al.  Reproducibility of volumetric intravascular ultrasound radiofrequency-based analysis of coronary plaque composition in vivo , 2008, The International Journal of Cardiovascular Imaging.

[77]  G. Mintz,et al.  Effect of Simvastatin on Coronary Lesion Site Remodeling: A Serial Intravascular Ultrasound Study , 2006, Cardiology.

[78]  Takashi Akasaka,et al.  Effect of statin therapy on coronary fibrous-cap thickness in patients with acute coronary syndrome: assessment by optical coherence tomography study. , 2009, Atherosclerosis.

[79]  Volkan Ozduran,et al.  Compensatory enlargement of human coronary arteries during progression of atherosclerosis is unrelated to atheroma burden: serial intravascular ultrasound observations from the REVERSAL trial. , 2006, European heart journal.

[80]  Raimund Erbel,et al.  Spectrum of remodeling behavior observed with serial long-term (>/=12 months) follow-up intravascular ultrasound studies in left main coronary arteries. , 2004, The American journal of cardiology.

[81]  C J Slager,et al.  ECG-gated three-dimensional intravascular ultrasound: feasibility and reproducibility of the automated analysis of coronary lumen and atherosclerotic plaque dimensions in humans. , 1997, Circulation.